Neuronal damage and its relation to dementia in acquired immunodeficiency syndrome (AIDS)

Pathobiology

Volumn 64, Issue 6, 1996, Pages 295-307

  Trillo Pazos, G ^a   Everall, Ian P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

AIDS; Cytokines; Gpl20; HIV proteins; HIV associated dementia; Kat; Nef; Neuronal loss

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 120; INTERLEUKIN 1; INTERLEUKIN 6; NEF PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOENCEPHALOPATHY; NERVE CELL LESION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD DISEASE; VASCULITIS; VIRUS INFECTIVITY; VIRUS MENINGITIS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030431222     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164064     Document Type: Article

References (126)

1. Gallo RC: Human retroviruses in the second decade: A personal perspective, Nature Med 1995;1:753-759.
2. Centers for Disease Control: Pneumocystis pneumonia-Los Angeles, Mort Morb Weekly Rep 1981;30:250-252.
3. Centers for Disease Control: Kaposi sarcoma and Pneumocystis pneumonia among homosexual men in New York and California, Mort Morb Weekly Rep 1981:30:305-308.
4. Wei X, Ghosh SK, Taylor ML, Johnson VA, et al: Viral dynamics in IT IV-1 infection, Nature 1995:373: 117-122.
5. Ho DD, Neumann AU, Perelson AS, Chen W, et al: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection, Nature 1995;373:123-126.
6. Pantalco G, Fauci AS: New concepts in the immunopathogcnesis of HIV infection, Annu Rev Immunol 1995:13:487-512.
7. Snider WD, Simpson DM, Nielsen S, Gold JWM, Metroka CE, Posner JB: Neurological complications of AIDS, Analysis of 50 patients, Ann Neurol 1983:14:403-418.
8. Everall IP, Lantos PL: The neuropathology of HIV: A review of the first 10 years, Int Res Psychoanal 1991;3:307-320.
9. Lipton SA, Gendclman HE: Dementia associated with acquired immunodeficiency syndrome, N Engl J Med 1995:332:934-940.
10. Glass JD, Johnson RT: IIIV and the brain, Annu Rev Neurosci 1996;19:1-26.
11. An SF, Ciardi A, Giomclto B, Scaravilli T, Gray F, Scaravilli F: Investigation on the MHC class II and cytokines and detection of HIV-1 DNA within the brain of asymptomatic and symptomatic HIV-1 positive patients, Acta Neuropathol 1996;91:494-503.
12. Gray F, Scaravilli F, Everall I, Chretien F, An S, Boche D, Adle-Biassette H, Wingertsmann L, Durigon M, Hurtrcl B, Chiodi F, Bell J, Lantos PL: Neuropathology of early H1V-I infection, Brain Pathol 1996;6:1-15.
13. Donaldson YK, Bell JE, Ironside JW, Brettle RP, Robertson JR, Busuttil A, Simmonds P: Redistribution of HIV outside the lymphoid system with onset of AIDS, Lancet 1994:343: 382-385.
14. Notlet H, Gendelman HE: Unraveling the neu-roimmune mechanisms associated HIV-1 associated cognitive/motor complex, Immunol Today 1995;16:441-448.
15. Nottet HSLM, Persidsky Y, Sasseville VG, Zhai Q-H, Bock P, Sharer LR, McComb RD, Swindells S, Sodcrland C, Hendelman HE: Mechanisms of transendolhclial migration of HIV-I infected monocytes into the brain, J Immunol 1996;156:1284-1295.
16. Epstein LG, Gendelman HE: HIV-I infection of the nervous system pathogenetic mechanisms, Ann Neurol 1993:33:429-436.
17. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Dewey R, Chesebro B: Distinct HIV-I env sequences arc associated with neu-tropism and neurovirulence, C'urr Top Microbiol Immunol 1996;202:89-101.
18. Schmidtmayerova H, Nottet HSL, Nuovo G, Raabe T, Flannagan CR, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, Sherry B: HIV-1 infection alters chemokine B peptide expression in human monocyte simplifications for recruitment of leukocytes into brain and lymph nodes, Proc Natl Acad Sci 1996:93:700-704.
19. Bagasra O, Lavi E, Bobroski L, Khalili K, Pcs-taner JP, Tawadros R, Pomcrantz RJ; Cellular reservoirs of HIV-I in theCNSofinfccted individuals identification by the combination of in situ polymerase chain reaction and immuno-histochemislry, AIDS 1996;10:573-585.
20. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD: Localization of HIV-1 in human brain using PCR/1SH and immunocytochemistry, Ann Neurol 1996; 39:705-711.
21. Wiley CA, Baldwin M, Achim CL: Expression of HIV regulatory and structural mRNA and the CNS, AIDS 1996; 10:843-847.
22. Geleziunas R, Schipper IIM, Wainberg MA: Pathogenesis and therapy of HIV-1 infection of the central nervous system, AIDS 1992:6: 1411-1426.
23. Tomatore C, Chandra R, Berger JR, Major EO: HIV-I infection of subcortical astrocytes in the pediatric CNS, Neurology 1994:44:481-487.
24. Naldini L, Blomcr U, Gallay P, Orv D, Mulligan R, Gage FH, Vcrma 1M, Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector, Science 1996:272:263-267.
25. Wiley CA: PCR-ISH-opening pandora's box? Ann Neuroi 1996:39:691-692.
26. Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, et al: HIV associated disese of the nervous system review of nomenclature and proposal for neuropathology-based terminology, Brain Pathol 1991; 1:143-152.
27. Navia BA, Cho E-S, Petito CK, Price RW: The AIDS dementia complex; II, Neuropathology, Ann Neurol 1986;19:525-535.
28. Everall IP, Gray F, Masliah E: Neuronal injury and apoptosis: in Gendelman, Lipton, Epstein, Swidnells (eds): Neurological and Neuropsychiatric Manifestations of HIV-I Infection, New York, Chapman &Hall, 1996.
29. Everall IP, Luthert PJ, Lantos PL: Neuronal loss in the frontal cortex in HIV infection, Lancet 1991;337:1119-1121.
30. Everall IP, Gray F, Barnes H, Durigon M, Luthert P, Lantos P: Neuronal loss in symptom-free HIV infection, Lancet 1992:340: 1413.
31. Wiley CA, Masliah E, Morey M, Lemere C, DcTcresa R, Grafe M, Hansen L, Terry R: Neocortical damage during HIV infection, Ann Neurol 1991;296:51-65.
32. Masliah E, Ge N, Morey M, De Teresa R, Terry RD, Wiley CA: Cortical dendritic pathology in human immunodeficiency virus encephalitis, Lab Invest 1992:66:285-291.
33. Masliah E, Ge N, Achim CL, DeTeresa R, Wiley CA: Patterns of neurodegeneration, NeuroAlDS 1996;1:161-173.
34. Ameisen JC, Estaquier J, Idziorek T, De Bels F: The relevance of apoptosis to AIDS pathogenesis, Trends Cell Biol 1995;5:27-32.
35. Adle-Biasseltc H, Levy M, Colontbcl M, Poron F, Natchcv S, Keophane C, Gray F: Neuronal apoptosis in HIV infection in adults, Ncuropa-thol Appl Neurobiol 1995;21:218-227.
36. Gelbard HA, James HJ, Sharer LR, Perry SW, Saito Y, Kazce AM, Blumberg BM, Epstein LG: Apoptotic neurones in brains from paediatric patients with HIVE and progressive encephalopathy, Neuropathol Appl Neurobiol 1995;21:208-217.
37. An SF, Giomctto B, Scaravilli T, Tavolato B, Gray F, Scaravilli F: Programmed cell death in brains of HIV-1 positive AIDS and pre-AIDS patients, Acta Neuropathol 1996;91:169-173.
38. Everall I, Luthert PJ, Lantos P: A review of neuronal damage in HIV infection, its assessment, possible mechanism and relationship to dementia, J Neuropathol Exp Neurol 1993:52: 561-566.
39. Masliah E, Nianfeng G, Achim CL, Wiley CA: Differential vulnerability of calbindin-immu-noreactive neurons in HIVE, J Neuropathol Exp Neurol 1995;54:350-357.
40. Masliah E: In vivo modelling of HIV-I mediated neurodegeneration, Am J Pathol 1996: 149:745-750.
41. Toggas SM, Masliah E, Mucke L: Prevention of HIV-1 gpl20 induced neuronal damage in the CNSof transgenic mice by the NMDA receptor antagonist memantine, Brain Res 1996:706: 303-307.
42. Hill JM, Mcrvis RF, Avidor R, Moody TW, Brenneman DE: HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates, Brain Res 1993;603:222-233.
43. Quinlan EM, Halpain S: Postsynaptic mechanisms for bidirectional control of MA02 phosphorylation by glutamate receptors, Neuron 1996;16:357-368.
44. Tymianski M, Tator CH: Normal and abnormal calcium homeostasis in neurons, a basis for the pathobiology of traumatic and ischaemic CNS injury, Neurosurgery 1996:38:1176-1195.
45. Diop AG, Dussartre C, Barthe D, Hujon J: Neuroprotective properties of calrctinin against the HIV-1 gp 120 toxicity, Neurosci Res Comrnun 1996:18:107-114.
46. Lipton SA: Models of neuronal injury in AIDS, another role for the NMDA receptor, TINS 1992:15/3:75-79.
47. Spencer DC, Price RW: HIV and The CNS, Annu Rev Microbiol 1992:46:655-693.
48. Ranki A, Lagcrstedt A, Ovod V, Aavik C, Krohn KJ: Expression kinetics and subcellular localisation of HIV-1 regulatory proteins Nef, tat and Rev in acutely and chronically infected lymphoid cells, Arch Virol 1994;139:365-378.
49. Kim YS, Panganiban AT: Examination of TAR-independcnt trans-activation by HIV-1 tat in human glial cells, J Neurosci Res 1996: 43:652-663.
50. Harrison MJG, McArthur JC: AIDS and Neurology, Edinburgh, Churchill Livingstone, 1995. pp 1-65.
51. Deng H, Liu R, Ellmeir W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR: Identification of a major co-receptor for primary isolates of HIV-I, Nature 1996:381:661-666.
52. Lipton SA, Suchcr NJ, Kaiser PK, Dreyer EB: Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity, Neuron 1991;7:111-118.
53. Brenneman DE, Westbrook GI, Fitzgerald SP, Ennist DL, Elkins KL, Rul TMR, Perl CB: Neuronal cell killing by the envelope protein of HIV and its prevention by VIP, Nature 1988: 335:629-643.
54. Dreyer EB, Kaiser PK, Offerman JT, Lipton SA: HIV-I coat protein neurotoxicity prevented by calcium channel antagonists, Science 1990;248:364-367.
55. Tak-Man L, Fallert CJ, Piser TM, Thayer SA: HIV envelope protein evokes intracellular calcium oscillations in rat hippocampal neurones, Brain Res 1992:594:189-196.
56. Pittaluga A, Pattarini R, Sereri P, Raiteri M: Human brain NMDA regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120. AIDS 1996:10:463-468.
57. Lipton SA, Rosenburg PA: EAA as a final common pathway for neurologic disorders, N Engl J Med 1994:330:613-622.
58. McEachem JC, Shaw CA: An alternative to the I, TP orthodoxy, a plasticitv-pathologv continuum model, Brain Res Rev 1996:22:51-92.
59. Barks JD, Sun R, Malinak C, Silverslcin FS: gpl20.an HIV-1 protein, increases susceptibility to hypoglycemic and ischaemic brain injury in perinatal rats, Exp Neurol 1995:132:123-133.
60. Bennct BA, Rusyniak DE, Hollingsworth CK: HIV-I gpl20 induced neurotoxicity to midbrain dopamine cultures, Brain Res 1995:705: 168-176.
61. Sardar AM, Czudck C, Reynolds CIP: Dopamine deficits in the brain, the neurochemical basis of parkinsonian symptoms in AIDS, Neuroreport 1996:7:910-912.
62. Giulian D, Wendt E, Vaca K, Noonan CA: The envelope glycoprotein of HIV-1 stimulates the release of neurotoxins from monocytes, Proc Natl Acad Sci 1993:90:2769-2773.
63. Giulian D, Yu J, Li X, Tom D, Li J, Wendt E, Lin SN, Schwarcz R, Noonan C: Study of receptor mediated neuroloxins released by HIV-I infected mononuclear phagocytes found in human brain, J Neurosci 1996; 16:3139-3153.
64. Dawson TM, Dawson VL: Gpl20 neurotoxicity in primary cortical cultures, Adv Neuroim-munol 1994;4:167-173.
65. Dawson VL, Dawson TM, Uhl GR, Snyder SH: HIV-I coat protein neurotoxicity mediated by NO in primary cortical cultures, Proc Natl Acad Sci 1996:90:3256-3259.
66. Bagctta G, Corasaniti MT, Aloe L, Berliocchi L, Costa N, Finazzi AA, Nistico G: Intracerebral injection of HIV-I coat protein gp 120 differentially affects the expression of NGF and NOS in the hippocampus of rat, Proc Natl Acad Sci 1996:93:928-933.
67. Bagetta G, Corasini MT, Berliocchi L, Navarra M, Finazzi-Agro A, Nistico G: HIV-1 gpl20 produces DNA fragmentation in the cerebral cortex of rat, Biochcm Biophys Res Commun 1995:211:130-136.
68. Mizrachi Y, Rodriguez I, Sweetnam PM, Rubinstein A, Volsky DJ: HIV type I infection of human cortical neuronal cells enhancement by select neuronal growth factors, AIDS Res Hum Retroviruses 1994:10:1593-1596.
69. Toggas SM, Masliah E, Rockenstcin EM, Rail GF, Abraham CR, Mucke L: Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice, Nature 1994:367:188-193.
70. Da Cunha A, Jackson RW, Vitkovic L: HIV-I non-spccifically stimulates production of TGF 1 transfer in primary astrocytes, J Neuroimmu-nol 1995:60:125-133.
71. Etniliani S, Van Lint C, Wolfgang F, Paras P, Ott M, Brady J, Verdin E: A point mutation in the HIV-I Tat responsive element is associated with postintegration latency, Proc Natl Acad Sci 1996:93:6377-6381.
72. Ramazotti E, Vignoli M, Re MC, Furlini G, La Placa M: Enhanced NF-B activation induced by TNF in stably tat-transfected cells is associated with the presence of cell surface bound tat protein, AIDS 1996:10:455-461.
73. Zauli G, Gibcllini D, Mazzoni M, Borgatti P, La Placa M, Capitani S: HIV-I tat protein protects lymphoid, epithelial and neuronal cell lines from death by apoptosis, Cancer Res 1993:53:4481-4485.
74. Goldstein G: HIV-I Tat as a potential AIDS vaccine, Nature Med 1996:1:960-964.
75. Magnuson DSK, Knudson BE, Geiger JD, Brownstonc RM, Nath A: HIV-1 tat activates non-N-methyl-D-aspartatc excitatory amino acid receptors and causes neurotoxicity, Ann Neurol 1995:37:373-380.
76. Albini A, Bcnclli R, Presta M, Rusnali M, Zichc M, Rubartelli A, Paglialunga G, Busso-lini F, Noonan D: HIV-I tat protein is heparin-binding angiogenic growth factor, Oncogene 1996:12:289-297.
77. Cupp C, Taylor JP, Khalili K, Amini S: Evidence for stimulation of the TGF-1 promoter by HIV-I tat in cells derived from CNS, Oncogene 1993;8:2231-2236.
78. Lafrcnie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S: HIV-I tat protein promotes cheinotaxis and invasive behaviour by monocytes, J Immunol 1996:157:974-977.
79. Rasty S, Thatikunta P, Gordon J, Khalili K, Amini S, Glorioso JC: HIV-1 Tat gene transfer to the murine CNS using a replication-defective herpes simplex virus vector stimulates TGF-1 gene expression, Proc Natl Acad Sci 1996:93:6073-6078.
80. Conant K, Meihui M, Nath A, Major EO: Extracellular HIV-1 Tat protein is associated with an increase in both NF-B binding and PKC activity in primary human astrocytes, J Virol 1996:70:1384-1389.
81. Wcstendorp MO, Shatrov VA, Schulzc-Osthoff K, Frank R, Kraft M, Los M, Krammer PH, Drge W, Lehmann V: HIV-I Tat potentiates TNF-induccd NF-activation and cytotoxicity by altering the cellular redox state, EM BO J 1995:14:546-554.
82. Nath A, Psooy K, Martin C, Knudscn B, Magnuson DSK, Haughey N, Geiger JD: Identification of HIV-I tat epitope that is ncurocxcitato-rv and neurotoxic, J Virol 1996:70:1475-1480.
83. Zauli G, Gibcllini D, Caputo A, Bassini A, Ncgrini M, Monne M, Mazzoni M, Capitani S: The HIV-I tat protein upregulatcs Bcl-2 gene expression in Jurkat-T cell lines and primary peripheral blood mononuclear cells, Blood 1995:86:3823-3824.
84. Opalenik SR, Shin JT, Wehby JN, Mahesh VK, Thompson JA: The HIV-I Tat protein induces the expression and extracellular appearance of acidic fibroblast growth factor, J Biol Chcm 1995;270:17457-17467.
85. Kolson DL, Buchhaltcr J, Collman R: Hellmig B, Farrell CF, Debouk C, Gonzalez-Scarano F: HIV-1 tat alters normal organisation of neurons and astrocytes in primary rodent brain cell cultures RGD sequence dependence, AIDS Res Hum Retroviruses 1993:9:677-685.
86. Philippon V, Vellutini C, Gambarelli D, Har-kiss G, Arbuthnotl G, Metzger D, Roubin R, Filippi P: The basic domain of the lentiviral Tat protein is responsible for damage in mouse brain involvement of cytokines, Virology 1994: 205:519-529.
87. Ranki A, Nybcrg M, Ovod V, Haltia M, Elo-vaara I, Raininko R, Haapasalo H, Krohn K: Abundant expression of HIV net' and rev proteins in brain astrocytes in vivo is associated with dementia, AIDS 1995:9:1001-1008.
88. Miller MD, Greene WC: Is the Ncf protein of HIV-I required for pathogenesis? Trends Microbiol 1996;4:171-173.
89. Blumbcrg BM, Epstein LG, Saito Y, Chen D, Sharer LR, AnandR: HIV-1 ncf quasispecies in pathological tissue, J Virol 1992:66:5256-5264.
90. Saito Y, Sharer LR, Epstein MG, Michaels J, Mintz M, Louder M, Golding K, Blumbcrg BM: Overcxprcssion of ncf as a marker for restricted HIV-1 infection of astrocytes in postmortem paediatric central tissues, Neurology 1994;14:474-480.
91. Nath A, Hartfioper V, Furer M, Fowke KR: Infection ofhuman fetal astrocytes with HIV-I viral tropism and the role of cell to cell contact in viral transmission, J Ncuropathol Exp Neurol 1995:54:320-330.
92. Allwood WJ, Berger JR, Kaderman R, Torna-tore CS, Major EO: Human immunodeficiency virus type 1 infection of the brain, Clin Microbiol Rev 1993;6:339-366.
93. Dc SK, Mrash JW: HIV-I ncf inhibits a common activation pathway in NIH-3T3 cells, J Biol Chem 1996:269:6656-6660.
94. Harris M: The role of mvristylation in the interactions between HIV-I type Nef and cellular proteins, Biochcm Soc Trans 1995:23:557-561.
95. Hopkins SJ, Rothwell NJ: Cytokines and the nervous system expression and recognition, TINS 1995:18:83-88.
96. Rothwell NJ, Hopkins SJ: Cytokines and the nervous system actions and mechanisms of action, TINS 1995:18:130-136.
97. Merrdl JE, Benvenistc EN: Cytokines in inflammatory brain lesions helpful and harmful, TINS 1996:19:331-338.
98. Mcrr ll JE, Martincz-Maza O: Cytokines in AIDS associated nervous and immune system dysfunction, Methods Neurosci 1996; 17:243-266.
99. Wcssclingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM, Griffin JW, Griffin DE: Intracerebral cytokine mRNA expression in AIDS dementia, Ann Neurol 1993:33:576-582.
100. Tyor WR, Wcsselingh SI, Griffin JW, McArthur JC, Griffin DE: Unifying hypothesis for the pathogenesis of HAD, vacuolar myelopathy and sensory neuropathy, J AIDS Hum Retroviral 1995:9:379-388.
101. Yeung MC, Pulliam L, Lau AS: The HIV envelope protein gp!20 is toxic to human brain cell cultures through the induction of IL-6 and TNFa, AIDS 1995:9:137-143.
102. Wilt SG, Milward E, Zhou JM, Nagasato K, Parton H, Rusten R, Griffin DE, Oiconnor M, Dubois-Dalcq M: In vitro evidence for a dual role of TNFa in HIV-1 encephalopathy, Ann Neural 1995:37:381-394.
103. Fine SM, Angel RA, Perry SW, Epstein LG, Rothstein JD, Dewhursl S, Gelbard HA: TNF inhibits glutamate uptake in primary human astrocytes, J Biol Chem 1996:271:15303-15306.
104. Gelbard HA, Dzcnko KA, Ccrro CD, Ccrro MD, Epstein LG: Neurotoxic effects of TNFa in primary human neuronal cultures arc mediated by activation of the glutamate AMPA receptor subtype implication for AIDS neuropathogenesis, Dev Neurosci 1993:15:417-422.
105. Baring M: Forging a path to cell death, Science 1996:273:735-737.
106. Bcnvcniste EN: Cytokine circuits in the brain: in Price RW, Perry SW (eds): HIV, AIDS and the brain, Assoc Res Nerv Ment Dis, New York, Raven Press, 1994. vol 72. pp 71-89.
107. Tyor WR, Glass JD, Ceriffm JW, Becker PS, McArthur JC, Bczman L, Griffin DE: Cytokine expression during AIDS, Ann Neurol 1992:31:349-360.
108. Vitkovic L, Da Cunha A, Tyor WR: Cytokine expression and pathogenesis in AIDS brain: in Price RW, Perry SW (eds): HIV, AIDS and the brain, Assoc Res Nerv Ment Dis, New York, Raven Press, 1994. vol 72. pp 203-223.
109. Catalan J: HIV associated dementia: Review of some conceptual and terminological problems, Int Rev Psychiatry 1991:3:321-330.
110. Janssen RS, Comblath DR, Epstein LG, et al: Nomenclature and research case definitions for neurological manifestations of HIV-1 infection, Neurology 1991:417:78-85.
111. Everall IP: Neuropsychiatric aspects of HIV infection, J Neurol Ncurosurg Psychiatry 1995:58:399-401.
112. Grant I, Heaton RK, HNRC group: Neuro-cognitivc disorders in H1V-I infection, Curr Top Microbiol Immunol 1995:202:11-32.
113. Glass JD, Wcsselingh SL, Seines OA, McArthur JC: Clinicai-neuropathological correlation in HIV-associated dementia, Neurology 1993:43:2230-2237.
114. Glass JD, Fedor H, Wesselingh SL, McArthur JC: Immunocytochcmical quantitation of HIV in the brain, correlations w ith dementia, Ann Neurol 1995:38:755-762.
115. Sharer LR: Pathology of HIV-1 infection in the CNS, A review, J Ncuropathol Exp Neurol 1992;51:3-11.
116. Asare E, Dunn G, Glass J, McArthur J, Lu-thcrt P, Lantos P, Everall I: Neuronal pattern correlates with the severity of HIV associated dementia complex, Ant J Pathol 1996:148: 31-38.
117. Shrikant P, Benos DJ, Tang LP, Bcnvcniste EN: HIV-I glycoprotein 120enhancesICAM-I gene expression in glial cells, J Immunol 1996:156:1307-1314.
118. Anlia R, Halloran ME: Recent developments in theories of pathogenesis of AIDS, Trends Microbiol 1996:4:282-285.
119. Achim CL, Wiley CA: Inflammation in AIDS and the role of the macrophage in brain pathology, Curr Opin Neurol 1996:9:221-225.
120. Senscnbrenner M: The ncurotrophic activity of FGF, Prog Neurobiol 1993:41:683-704.
121. McArthur JC: Neurologic diseases associated with HIV-1 infection, Curr Opin Infect Dis 1995:8:74-84.
122. Koka P, He K, Zack JA, Kitchen S, Peacock W, Fried I, Tran T, Yashar S, Merrill JE: HIV-1 envelope proteins induce IL-1. TNF and NO in glial cultures derived from fetal, neonatal and adult human brain, J Exp Med 1995:182:941-952.
123. Wu P, Price P, Du B, Hatch WC, Terwilliger EF: Direct cytotoxicity of HIV-I envelope protein gp!20 on human NT neurons, Neuroreporl 1996;7:1045-1049.
124. Muekc L, Abraham CR, Ruppe MD, Rockcn-stein EM, Toggas SM, Mallory M, Alford M, Masliah E: Protection against HIV-I gp 120 induced brain damage by neuronal expression of human amyloid precursor protein, J Exp Med 1995:181:1551-1556.
125. Hofman FM, Dohadwala MM, Wriglu AD, Hinton DR, Walker SM: Exogenous tat activates CNS derived endothelial cells, J Neu-roimmunol 1994:54:19-28.
126. Lafenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S: HIV-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells, A mechanism of HIV pathogensis, J Immunol 1996:156:1638-1645.